SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

The symbol $OPENAI CRYPTO, presented as "OpenAI PreStocks," is trending amidst widespread community discussion labeling it a scam and questioning its legitimacy due to its clear lack of affiliation with the actual OpenAI company.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Recent listings on exchanges such as KuCoin Alpha and Bitget, coupled with developer efforts to stabilize the market and paid fees for upcoming Tier-1 listings, are fueling intense community discussion around JYAI CRYPTO's potential as the "next PEPE" in the AI memecoin sector.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amidst escalating speculation of a potential buyout from major tech players like SpaceX or Amazon, leveraging its uniquely valuable n53 spectrum and deepening Apple partnership. The community is eagerly anticipating key FCC decisions regarding spectrum use and the deployment of Globalstar's C-3 constellation, seen as critical catalysts, with investors widely believing the company is significantly undervalued for its foundational role in direct-to-device connectivity and emerging IoT solutions.

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

LENZ Therapeutics Inc.

LENZ Therapeutics is generating significant conversation driven by the strong initial adoption of its VIZZ eye drop for presbyopia and the upcoming high-profile direct-to-consumer marketing campaign featuring Sarah Jessica Parker, fueling widespread community excitement over its vast market potential and notable short interest.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences is seeing immense speculative interest and extreme volatility after its Breakthrough Therapy Designation for a rare disease treatment catalyzed a dramatic price surge, drawing high analyst price targets. Community discussion is rife with debate over a recent institutional private placement at a substantial discount, balancing optimism for accelerated approval against concerns of dilution and further price swings.

Berachain

Berachain (BERA) is attracting significant attention due to its innovative Proof-of-Liquidity consensus, rapid Total Value Locked (TVL) growth, and recent ecosystem expansions like the Bectra upgrade and new BTC-focused vaults. The community is sharply divided between those anticipating a major breakout, citing strong fundamentals and institutional interest, and skeptics wary of past performance and token distribution concerns.

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals is generating significant buzz following positive preliminary data from its ORIC-944 prostate cancer trial and a strategic investment and clinical partnership with Pfizer. This clinical momentum, coupled with high short interest, is fueling community speculation about a potential short squeeze and future growth.

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals is trending following the FDA approval of EKTERLY, the first and only oral on-demand treatment for hereditary angioedema, generating community discussion around its strong initial sales, potential for significant market adoption, and a possible short squeeze driven by high institutional ownership and substantial short interest.

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

CME Group Inc - Ordinary Shares - Class A

CME Group Inc

CME Group is trending following strong financial results driven by record trading volumes, with community discussion highlighting its strategic expansion into prediction markets and crypto derivatives as a stable hedge against market uncertainty.

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Progressive Corp.

Progressive Corp

Progressive (PGR) is drawing significant attention following strong recent earnings that showcased robust performance and a healthy combined ratio, though the stock has experienced a notable price pullback. The community is actively discussing if this dip, partially attributed to post-dividend adjustments and analyst re-ratings, presents a prime buying opportunity given the company's strong fundamentals and leading position in the insurance sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Princeton Bancorp (NASDAQ:BPRN) Downgraded to "Strong Sell" Rating by Zacks Research

Zacks Research lowered Princeton Bancorp from a "hold" rating to a "strong sell" rating in a report on Tuesday...

Princeton Bancorp (NASDAQ:BPRN) Price Target Raised to $37.50

Hovde Group upped their target price on shares of Princeton Bancorp from $35.00 to $37.50 and gave the stock a "market perform" rating in a report on Tuesday...

Princeton Bancorp (BPRN) Q4 Earnings and Revenues Miss Estimates

Princeton Bancorp (BPRN) delivered earnings and revenue surprises of -3.74% and -6.75%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Princeton Bancorp (NASDAQ:BPRN) Issues Earnings Results

Princeton Bancorp (NASDAQ:BPRN - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate...

Princeton Bancorp Announces YTD & Fourth Quarter 2025 Results

Princeton Bancorp, Inc. (the Company) (NASDAQ - BPRN), the bank holding company for The Bank of Princeton (the Bank), today reported its unaudited financial condition at, and its results of...

Princeton Bancorp, Inc. (NASDAQ:BPRN) Plans Quarterly Dividend of $0.35

Princeton Bancorp, Inc. (NASDAQ:BPRN) announced a quarterly dividend on Wednesday, January 21st. Stockholders of record on Wednesday, February 4th will be given a dividend of 0.35 per share on...

Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend

Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend PR Newswire PRINCETON, N.J., Jan. 21...

Princeton Bancorp (BPRN) to Release Earnings on Tuesday

Princeton Bancorp (NASDAQ:BPRN) will be releasing its Q4 2025 earnings before the market opens on Tuesday, January 27. (View Earnings Report at...

Princeton Bancorp, Inc. (NASDAQ:BPRN) Short Interest Down 30.3% in December

Princeton Bancorp, Inc. (NASDAQ:BPRN - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 37,540 shares, a...

Princeton Bancorp (NASDAQ:BPRN) Trading Up 1.1% - Here's What Happened

Princeton Bancorp (NASDAQ:BPRN) Trading Up 1.1% - Should You Buy...

Princeton Bancorp, Inc. operates as a bank holding company. It is a full-service financial institution that provides business and personal banking. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The company was founded in 2017 and is headquartered in Princeton, NJ.

Princeton Bancorp Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

Current Price	$36.42
Prev Close	$36.13
Open	$36.64
Dividend Yield	3.60%
50-Day Moving Average	$35.50
Beta	0.61
Avg. Volume	15,335.40
PE Ratio	13.39

52-Week High	$37.99
52-Week Low	$27.25
Market Capitalization	$254.58M
EPS (Annual)	$2.71
Price to Book	0.91
Revenue Per Employee	$562,720.65
Enterprise Value/EBITDA	N/A

BPRN
Bank of Princeton

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BPRN News

BPRNBank of Princeton